Giuseppe Badalamenti

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

George D. Demetri, Peter Reichardt, Yoon‐Koo Kang et al. · The Lancet · 2012 · 1.4K citations · Full text

Gastrointestinal Oncology, Medicine, Pharmacology +6

Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study

Paola Sperone, Annamaria Ferrero, Fulvia Daffara et al. · Endocrine Related Cancer · 2010 · 162 citations · Full text

Advanced Acc Progressing, Second-/third-line Chemotherapy, Adrenocortical Carcinoma +13

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases

Daniele Santini, Sandro Barni, Salvatore Intagliata et al. · Scientific Reports · 2015 · 136 citations · Full text

Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study

Daniele Santini, Marco Tampellini, Bruno Vincenzi et al. · Annals of Oncology · 2012 · 129 citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Medicine +7

Activin A circulating levels in patients with bone metastasis from breast or prostate cancer

Gaetano Leto, Lorena Incorvaia, Giuseppe Badalamenti et al. · Clinical & Experimental Metastasis · 2006 · 115 citations

Urology, Breast Oncology, Medicine +9